Existing collaborations between the two partners are already bringing together scientists in the fields of regenerative medicine, public health and genetics research.
Major new joint initiatives in the commonest diseases affecting people in northern Europe, such as diabetes, heart disease, cancer, infection, inflammation and degenerative brain disorders including multiple sclerosis are planned.
Training the next generation of research leaders will also be a focus for the partnership.
The alliance builds on a successful postgraduate student exchange that has been in place since 1999. The Karolinska Institute is one of the world’s leading medical universities. It accounts for over 40% of the medical academic research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences.
Professor Sir Timothy O’Shea, Principal and Vice Chancellor of the University of Edinburgh, said: “Our institutions have enjoyed successful collaborations for many years and I am delighted that we have formalised our joint objectives and shared goals. Expanding our linkages will bring significant benefits for medical and healthcare research, teaching and learning.”
Professor Anders Hamsten, Vice-Chancellor of Karolinska Institutet said: “The University of Edinburgh and Karolinska Institutet have common interests and our respective strengths and complementarities can provide synergies of great value to both institutions. Formalising our joint efforts is one step in our current and planned collaborations in medical and healthcare research and education.”
Prof Jonathan Seckl, Vice Principal for Research at the University of Edinburgh, added: “Both Scotland and Sweden have highly developed health systems and a tradition of outstanding public health and experimental medicine research. Bringing the two top medical universities from each nation together to address the most pressing health needs of our populations is rational.”